Megestrol Tablets

— THERAPEUTIC CATEGORIES —
  • Breast cancer
  • Gynecologic cancers

Megestrol Tablets Generic Name & Formulations

General Description

Megestrol acetate 20mg, 40mg; scored tabs.

Pharmacological Class

Progestin.

How Supplied

Contact supplier.

Megestrol Tablets Indications

Indications

Palliative treatment of advanced breast carcinoma.

Megestrol Tablets Dosage and Administration

Adult

40mg 4 times daily.

Children

Not applicable.

Megestrol Tablets Contraindications

Contraindications

Pregnancy.

Megestrol Tablets Boxed Warnings

Not Applicable

Megestrol Tablets Warnings/Precautions

Warnings/Precautions

History of thromboembolic disease. Diabetes. Monitor for adrenal insufficiency. Fetal toxicity. Obtain (–) pregnancy test prior to initiation. Advise females of reproductive potential to use effective contraception during therapy. Nursing mothers: not recommended.

Megestrol Tablets Pharmacokinetics

See Literature

Megestrol Tablets Interactions

Interactions

May increase insulin requirements. Decreases indinavir levels.

Megestrol Tablets Adverse Reactions

Adverse Reactions

Weight gain, thromboembolic events, heart failure, GI upset, edema, breakthrough menstrual bleeding, dyspnea, tumor flare, hyperglycemia, alopecia, hypertension, carpal tunnel syndrome, mood changes, hot flashes, malaise, asthenia, lethargy, sweating, rash.

Megestrol Tablets Clinical Trials

See Literature

Megestrol Tablets Note

Notes

Formerly known under the brand name Megace.

Megestrol Tablets Patient Counseling

See Literature

Megestrol Tablets Generic Name & Formulations

General Description

Megestrol acetate 20mg, 40mg; scored tabs.

Pharmacological Class

Progestin.

How Supplied

Contact supplier.

Megestrol Tablets Indications

Indications

Palliative treatment of advanced endometrial carcinoma.

Megestrol Tablets Dosage and Administration

Adult

40–320mg daily in divided doses.

Children

Not applicable.

Megestrol Tablets Contraindications

Contraindications

Pregnancy.

Megestrol Tablets Boxed Warnings

Not Applicable

Megestrol Tablets Warnings/Precautions

Warnings/Precautions

History of thromboembolic disease. Diabetes. Monitor for adrenal insufficiency. Fetal toxicity. Obtain (–) pregnancy test prior to initiation. Advise females of reproductive potential to use effective contraception during therapy. Nursing mothers: not recommended.

Megestrol Tablets Pharmacokinetics

See Literature

Megestrol Tablets Interactions

Interactions

May increase insulin requirements. Decreases indinavir levels.

Megestrol Tablets Adverse Reactions

Adverse Reactions

Weight gain, thromboembolic events, heart failure, GI upset, edema, breakthrough menstrual bleeding, dyspnea, tumor flare, hyperglycemia, alopecia, hypertension, carpal tunnel syndrome, mood changes, hot flashes, malaise, asthenia, lethargy, sweating, rash.

Megestrol Tablets Clinical Trials

See Literature

Megestrol Tablets Note

Notes

Formerly known under the brand name Megace.

Megestrol Tablets Patient Counseling

See Literature